Changes in Ownership

Alaunos Therapeutics, Inc. Filed 2021-01-06 Acc 0001209191-21-002174

EVP, GM Cell Therapy sold 21,620 shares at $2.72 ($58,806)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
De Groot Eleanor EVP, GM Cell Therapy	2021-01-04	Sale	−21,620	$2.72	$58,806	206,413	D
Open-market sales · 21,620 sh · avg $2.72 · $58,806